Nordmann S, et al. - Researchers here assessed whether cannabis use in human immunodeficiency virus (HIV) and hepatitis C virus (HCV) co-infected patients was associated with a reduced risk of steatosis, measured by ultrasound examination. Findings suggested daily cannabis use as a protective factor against steatosis in HIV-HCV co-infected patients. Findings thus support the necessity for a clinical evaluation of cannabis-based pharmacotherapies in this population.